Testicular Cancer Incidence in Eight Northern European Countries: Secular and Recent Trends

  • Lorenzo Richiardi
    1Department of Medical Epidemiology and Biostatistics and
  • Rino Bellocco
    1Department of Medical Epidemiology and Biostatistics and
  • Hans-Olov Adami
    1Department of Medical Epidemiology and Biostatistics and
  • Anna Torrång
    1Department of Medical Epidemiology and Biostatistics and
  • Lotti Barlow
    3Centre for Epidemiology, National Board of Health and Welfare, Stockholm, Sweden;
  • Timo Hakulinen
    5Finnish Cancer Registry, Helsinki, Finland;
  • Mati Rahu
    6Department of Epidemiology and Biostatistics, Institute of Experimental and Clinical Medicine and
  • Aivars Stengrevics
    8Latvian Oncology Center, Riga, Latvia;
  • Hans Storm
    9Cancer Prevention & Documentation, Danish Cancer Society, Copenhagen, Denmark;
  • Steinar Tretli
    10Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway;
  • Juozas Kurtinaitis
    11Lithuanian Cancer Registry, Vilnius University Oncology Institute, Lithuania; and
  • Jerzy E. Tyczynski
    12Unit of Descriptive Epidemiology, IARC, Lyon, France
  • Olof Akre
    2Clinical Epidemiology Unit, Department of Medicine, Karolinska Hospital, Karolinska Institutet,

抄録

<jats:title>Abstract</jats:title> <jats:p>Objective: Striking geographic variation and marked increasing secular trends characterize the incidence of testicular cancer. However, it is not known whether these patterns have attenuated in recent years and whether they are similar for seminomas and nonseminomas, the two main histologic groups of testicular cancer.</jats:p> <jats:p>Method: Cancer registry data, including 27,030 testicular cancer cases, were obtained from Denmark, Estonia, Finland, Latvia, Lithuania, Norway, Poland, and Sweden. Between 57 (Denmark) and 9 (Poland) years of registration were covered. Country-specific temporal trends were estimated, with focus on the last decade and seminomas and nonseminomas. Data from the Nordic countries were further analyzed using an age-period-cohort approach.</jats:p> <jats:p>Results: Age-standardized incidence rates increased annually by 2.6% to 4.9% during the study period, with marginal differences between seminomas and nonseminomas. In the last decade, the increasing trend attenuated only in Denmark (annual change, −0.3%; 95% confidence interval, −1.5 to 0.9). In 1995, the highest and the lowest age-standardized incidence rates (per 105) were 15.2 in Denmark and 2.1 in Lithuania. Incidence rates (i.e., for all cancers and for seminomas and nonseminomas, separately) depended chiefly on birth cohort rather than on calendar period of diagnosis (although both birth cohort and period determined the Danish incidence rates).</jats:p> <jats:p>Conclusions: Testicular cancer incidence is still increasing, with the exception of Denmark, and a large geographic difference exists. The increasing trend is mainly a birth cohort phenomenon also in recent cohorts. Temporal trends for seminomas and nonseminomas are similar, which suggests that they share important causal factors.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ